Cargando…

Utilizing the ultrasensitive Schistosoma up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA) assay for sample pooling-strategies

BACKGROUND: Methodological applications of the high sensitivity genus-specific Schistosoma CAA strip test, allowing detection of single worm active infections (ultimate sensitivity), are discussed for efficient utilization in sample pooling strategies. Besides relevant cost reduction, pooling of sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Corstjens, Paul L. A. M., Hoekstra, Pytsje T., de Dood, Claudia J., van Dam, Govert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664425/
https://www.ncbi.nlm.nih.gov/pubmed/29089064
http://dx.doi.org/10.1186/s40249-017-0368-1
_version_ 1783274995326124032
author Corstjens, Paul L. A. M.
Hoekstra, Pytsje T.
de Dood, Claudia J.
van Dam, Govert J.
author_facet Corstjens, Paul L. A. M.
Hoekstra, Pytsje T.
de Dood, Claudia J.
van Dam, Govert J.
author_sort Corstjens, Paul L. A. M.
collection PubMed
description BACKGROUND: Methodological applications of the high sensitivity genus-specific Schistosoma CAA strip test, allowing detection of single worm active infections (ultimate sensitivity), are discussed for efficient utilization in sample pooling strategies. Besides relevant cost reduction, pooling of samples rather than individual testing can provide valuable data for large scale mapping, surveillance, and monitoring. METHOD: The laboratory-based CAA strip test utilizes luminescent quantitative up-converting phosphor (UCP) reporter particles and a rapid user-friendly lateral flow (LF) assay format. The test includes a sample preparation step that permits virtually unlimited sample concentration with urine, reaching ultimate sensitivity (single worm detection) at 100% specificity. This facilitates testing large urine pools from many individuals with minimal loss of sensitivity and specificity. The test determines the average CAA level of the individuals in the pool thus indicating overall worm burden and prevalence. When requiring test results at the individual level, smaller pools need to be analysed with the pool-size based on expected prevalence or when unknown, on the average CAA level of a larger group; CAA negative pools do not require individual test results and thus reduce the number of tests. RESULTS: Straightforward pooling strategies indicate that at sub-population level the CAA strip test is an efficient assay for general mapping, identification of hotspots, determination of stratified infection levels, and accurate monitoring of mass drug administrations (MDA). At the individual level, the number of tests can be reduced i.e. in low endemic settings as the pool size can be increased as opposed to prevalence decrease. CONCLUSIONS: At the sub-population level, average CAA concentrations determined in urine pools can be an appropriate measure indicating worm burden. Pooling strategies allowing this type of large scale testing are feasible with the various CAA strip test formats and do not affect sensitivity and specificity. It allows cost efficient stratified testing and monitoring of worm burden at the sub-population level, ideally for large-scale surveillance generating hard data for performance of MDA programs and strategic planning when moving towards transmission-stop and elimination.
format Online
Article
Text
id pubmed-5664425
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56644252017-11-08 Utilizing the ultrasensitive Schistosoma up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA) assay for sample pooling-strategies Corstjens, Paul L. A. M. Hoekstra, Pytsje T. de Dood, Claudia J. van Dam, Govert J. Infect Dis Poverty Research Article BACKGROUND: Methodological applications of the high sensitivity genus-specific Schistosoma CAA strip test, allowing detection of single worm active infections (ultimate sensitivity), are discussed for efficient utilization in sample pooling strategies. Besides relevant cost reduction, pooling of samples rather than individual testing can provide valuable data for large scale mapping, surveillance, and monitoring. METHOD: The laboratory-based CAA strip test utilizes luminescent quantitative up-converting phosphor (UCP) reporter particles and a rapid user-friendly lateral flow (LF) assay format. The test includes a sample preparation step that permits virtually unlimited sample concentration with urine, reaching ultimate sensitivity (single worm detection) at 100% specificity. This facilitates testing large urine pools from many individuals with minimal loss of sensitivity and specificity. The test determines the average CAA level of the individuals in the pool thus indicating overall worm burden and prevalence. When requiring test results at the individual level, smaller pools need to be analysed with the pool-size based on expected prevalence or when unknown, on the average CAA level of a larger group; CAA negative pools do not require individual test results and thus reduce the number of tests. RESULTS: Straightforward pooling strategies indicate that at sub-population level the CAA strip test is an efficient assay for general mapping, identification of hotspots, determination of stratified infection levels, and accurate monitoring of mass drug administrations (MDA). At the individual level, the number of tests can be reduced i.e. in low endemic settings as the pool size can be increased as opposed to prevalence decrease. CONCLUSIONS: At the sub-population level, average CAA concentrations determined in urine pools can be an appropriate measure indicating worm burden. Pooling strategies allowing this type of large scale testing are feasible with the various CAA strip test formats and do not affect sensitivity and specificity. It allows cost efficient stratified testing and monitoring of worm burden at the sub-population level, ideally for large-scale surveillance generating hard data for performance of MDA programs and strategic planning when moving towards transmission-stop and elimination. BioMed Central 2017-11-01 /pmc/articles/PMC5664425/ /pubmed/29089064 http://dx.doi.org/10.1186/s40249-017-0368-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Corstjens, Paul L. A. M.
Hoekstra, Pytsje T.
de Dood, Claudia J.
van Dam, Govert J.
Utilizing the ultrasensitive Schistosoma up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA) assay for sample pooling-strategies
title Utilizing the ultrasensitive Schistosoma up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA) assay for sample pooling-strategies
title_full Utilizing the ultrasensitive Schistosoma up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA) assay for sample pooling-strategies
title_fullStr Utilizing the ultrasensitive Schistosoma up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA) assay for sample pooling-strategies
title_full_unstemmed Utilizing the ultrasensitive Schistosoma up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA) assay for sample pooling-strategies
title_short Utilizing the ultrasensitive Schistosoma up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA) assay for sample pooling-strategies
title_sort utilizing the ultrasensitive schistosoma up-converting phosphor lateral flow circulating anodic antigen (ucp-lf caa) assay for sample pooling-strategies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664425/
https://www.ncbi.nlm.nih.gov/pubmed/29089064
http://dx.doi.org/10.1186/s40249-017-0368-1
work_keys_str_mv AT corstjenspaullam utilizingtheultrasensitiveschistosomaupconvertingphosphorlateralflowcirculatinganodicantigenucplfcaaassayforsamplepoolingstrategies
AT hoekstrapytsjet utilizingtheultrasensitiveschistosomaupconvertingphosphorlateralflowcirculatinganodicantigenucplfcaaassayforsamplepoolingstrategies
AT dedoodclaudiaj utilizingtheultrasensitiveschistosomaupconvertingphosphorlateralflowcirculatinganodicantigenucplfcaaassayforsamplepoolingstrategies
AT vandamgovertj utilizingtheultrasensitiveschistosomaupconvertingphosphorlateralflowcirculatinganodicantigenucplfcaaassayforsamplepoolingstrategies